In response to the China outbreak of 2019-nCoV, Biotron is now focused on testing a select set of these compounds to see if they can destroy the virus.
Within its proprietary small molecule compound library Biotron has over 30 compounds with good activity against a range of coronaviruses, including human coronaviruses that cause mild, cold-like symptoms as well as the SARS coronavirus that was responsible for the outbreak of that virus in 2003. These compounds can reduce the levels of coronavirus by 90 - 100% in infected cell cultures. Importantly, several compounds have broad-spectrum activity against multiple strains of coronaviruses.
BIT Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
